{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:51:00Z","timestamp":1765889460493,"version":"build-2065373602"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"unspecified","delay-in-days":75,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>Within an infrastructure to monitor vaccine effectiveness (VE) against hospitalization due to COVID-19 and COVID-19 related deaths from November 2022 to July 2023 in seven countries in real-world conditions (VEBIS network), we compared two approaches: (a) estimating VE of the first, second or third COVID-19 booster doses administered during the autumn of 2022, and (b) estimating VE of the autumn vaccination dose regardless of the number of prior doses (autumnal booster approach). Retrospective cohorts were constructed using Electronic Health Records at each participating site. Cox regressions with time-changing vaccination status were fit and site-specific estimates were combined using random-effects meta-analysis. VE estimates with both approaches were mostly similar, particularly shortly after the start of the vaccination campaign, and showed a similar timing of VE waning. However, autumnal booster estimates were more precise and showed a clearer trend, particularly compared to third booster estimates, as calendar time increased after the vaccination campaign and during periods of lower SARS-CoV-2 activity. Moreover, the decrease in protection by increasing calendar time was more clear and precise than when comparing protection by number of doses. Therefore, estimating VE under an autumnal booster framework emerges as a preferred method for future monitoring of COVID-19 vaccination campaigns.<\/jats:p>","DOI":"10.1017\/s0950268825000317","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T22:46:52Z","timestamp":1742165212000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022\/23"],"prefix":"10.1017","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-3012","authenticated-orcid":false,"given":"Susana","family":"Monge","sequence":"first","affiliation":[{"name":"National Centre of Epidemiology, Institute of Health Carlos III"},{"name":"CIBER on Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3789-8309","authenticated-orcid":false,"given":"James","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Nicolay","sequence":"additional","affiliation":[{"name":"European Centre for Disease Prevention and Control (ECDC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-4613","authenticated-orcid":false,"given":"Toon","family":"Braeye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izaak","family":"Van Evercooren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Holm","family":"Hansen","sequence":"additional","affiliation":[{"name":"Statens Serum Institut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne-Dorthe","family":"Emborg","sequence":"additional","affiliation":[{"name":"Statens Serum Institut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-7117","authenticated-orcid":false,"given":"Massimo","family":"Fabiani","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Sacco","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0"},{"name":"European Centre for Disease Prevention and Control"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6396-7265","authenticated-orcid":false,"given":"Jes\u00fas","family":"Castilla","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra \u2013 IdiSNA"},{"name":"CIBER on Epidemiology and Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-2277","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Mart\u00ednez-Baz","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra \u2013 IdiSNA"},{"name":"CIBER on Epidemiology and Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9067-090X","authenticated-orcid":false,"given":"Brechje","family":"de Gier","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hahn\u00e9","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-2778","authenticated-orcid":false,"given":"Hinta","family":"Meijerink","sequence":"additional","affiliation":[{"name":"Norwegian Institute of Public Health (NIPH)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja Br\u00e5then","family":"Kristoffersen","sequence":"additional","affiliation":[{"name":"Norwegian Institute of Public Health (NIPH)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-1499","authenticated-orcid":false,"given":"Ausenda","family":"Machado","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Soares","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Font\u00e1n-Vela","sequence":"additional","affiliation":[{"name":"National Centre of Epidemiology, Institute of Health Carlos III"},{"name":"Universidad de Alcal\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-0937","authenticated-orcid":false,"given":"Anthony","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-8404","authenticated-orcid":false,"given":"Esther","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6230-7209","authenticated-orcid":false,"given":"Baltazar","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"VEBIS-Lot 4 working group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"volume-title":") Pilot Protocol for a COVID-19 Vaccine Effectiveness Study Using Health Data Registries","year":"2022","key":"S0950268825000317_r30"},{"key":"S0950268825000317_r17","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.8.2300105"},{"key":"S0950268825000317_r13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200797"},{"volume-title":") Core Protocol for ECDC Studies of Vaccine Effectiveness against Symptomatic Laboratory-Confirmed Influenza or SARS-CoV-2 infection at Primary Care Level: Version 1.0","year":"2023","key":"S0950268825000317_r26"},{"key":"S0950268825000317_r32","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.30.2200551"},{"key":"S0950268825000317_r15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114228"},{"key":"S0950268825000317_r11","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.3.2300708"},{"volume-title":"Protocol for a COVID-19 Vaccine Effectiveness Study using Health Data Registries, v.2.0","year":"2024","key":"S0950268825000317_r31"},{"key":"S0950268825000317_r6","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.37.2200697"},{"key":"S0950268825000317_r5","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.1.2300670"},{"key":"S0950268825000317_r20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00374-2"},{"key":"S0950268825000317_r18","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyad114"},{"volume-title":"Interim Public Health Considerations for COVID-19 Vaccination Roll-Out during 2023","year":"2023","key":"S0950268825000317_r1"},{"key":"S0950268825000317_r23","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.32.2300397"},{"key":"S0950268825000317_r24","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.05.23295025"},{"key":"S0950268825000317_r16","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13195"},{"key":"S0950268825000317_r21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2302462"},{"volume-title":") Interim Analysis of COVID-19 Vaccine Effectiveness against Hospitalisation and Death Using Electronic Health Records in Six European Countries","year":"2023","key":"S0950268825000317_r25"},{"key":"S0950268825000317_r8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00309-7"},{"key":"S0950268825000317_r10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108891"},{"volume-title":") Core Protocol for ECDC VEBIS Studies of Vaccine Effectiveness against Hospitalisation with Severe Acute Respiratory Infection, Laboratory Confirmed with SARS-CoV-2 or with Seasonal Influenza \u2013 Version 2.0","year":"2023","key":"S0950268825000317_r27"},{"key":"S0950268825000317_r19","article-title":"Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults","author":"Lee","year":"2023","journal-title":"Clinical Infectious Diseases"},{"key":"S0950268825000317_r3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00152-0"},{"key":"S0950268825000317_r7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-075286"},{"key":"S0950268825000317_r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.02.020"},{"key":"S0950268825000317_r12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00292-4"},{"key":"S0950268825000317_r33","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1296"},{"key":"S0950268825000317_r9","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.1.2300703"},{"key":"S0950268825000317_r22","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00365-1"},{"key":"S0950268825000317_r28","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.39.20281-en"},{"volume-title":"Causal Inference: What if","year":"2020","author":"Hernan","key":"S0950268825000317_r34"},{"key":"S0950268825000317_r14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02249-2"},{"volume-title":") Protocol for a COVID-19 Vaccine Effectiveness Study Using Health Data Registries","year":"2023","key":"S0950268825000317_r29"},{"key":"S0950268825000317_r4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115481"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268825000317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:50:50Z","timestamp":1759848650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268825000317\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"alternative-id":["S0950268825000317"],"URL":"https:\/\/doi.org\/10.1017\/s0950268825000317","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"type":"print","value":"0950-2688"},{"type":"electronic","value":"1469-4409"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e54"}}